(3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)methanone → 9H-Xanthene-9-carboxylic acid (5-cyclopropylmethyl-[1,3,4]oxadiazol-2-yl)-amide
Reaction equation
CC1C=C(C)N([C:8]([CH:10]2[C:23]3[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=3[O:17][C:16]3[C:11]2=[CH:12][CH:13]=[CH:14][CH:15]=3)=[O:9])N=1.[CH:24]1([CH2:27][C:28]2[O:32][C:31]([NH2:33])=[N:30][N:29]=2)[CH2:26][CH2:25]1>>[CH:24]1([CH2:27][C:28]2[O:32][C:31]([NH:33][C:8]([CH:10]3[C:11]4[CH:12]=[CH:13][CH:14]=[CH:15][C:16]=4[O:17][C:18]4[C:19]3=[CH:20][CH:21]=[CH:22][CH:23]=4)=[O:9])=[N:30][N:29]=2)[CH2:26][CH2:25]1Participants
3
Procedure
The title compound, white solid, m.p. 234-236° C. and MS: m/e=347.1(M+H+) was prepared in accordance with the general method of example 48a from (3,5-dimethylpyrazol-1-yl)-(9H-xanthen-9-yl)-methanone and 5-cyclopropylmethyl-[1,3,4]oxadiazol-2-ylamine.
Sources & evidence
- ORD record
- ord-919ec43e26264e2c852db019c4012039
- Source dataset
- uspto-grants-2004_10
- Patent number
- US06803381B1
Reaction notes
Loading…